301
TITLE: Control of RNA initiation and elongation at the HIV promoter
AUTHORS: Daelemans, D; De Clercq, E; Vandamme, AM;
PUBLISHED: 2000, SOURCE: AIDS Reviews, VOLUME: 2, ISSUE: 4
INDEXED IN: Scopus
IN MY: ORCID
302
TITLE: Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy
AUTHORS: Van Vaerenbergh, K; Van Laethem, K; Van Wijngaerden, E; Schmit, JC; Schneider, F; Ruiz, L; Clotet, B; Verhofstede, C; Van Wanzeele, F; Muyldermans, G; Simons, P; Stuyver, L; Hermans, P; Evans, C; De Clercq, E; Desmyter, J; Vandamme, AM;
PUBLISHED: 2000, SOURCE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 16, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
303
TITLE: Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients
AUTHORS: Van Laethem, K; Schmit, JC; Pelemans, H; Balzarini, J; Witvrouw, M; Perez Perez, MJ; Camarasa, MJ; Esnouf, RM; Aquaro, S; Cenci, A; Perno, CF; Hermans, P; Sprecher, S; Ruiz, L; Clotet, B; Van Wijngaerden, E; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLISHED: 2000, SOURCE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 16, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
304
TITLE: Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II)  Full Text
AUTHORS: Lewis, MJ; Novoa, P; Ishak, R; Ishak, M; Salemi, M; Vandamme, AM; Kaplan, MH; Hall, WW;
PUBLISHED: 2000, SOURCE: VIROLOGY, VOLUME: 271, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
305
TITLE: Evolutionary strategies of human T-cell lymphotropic virus type II  Full Text
AUTHORS: Vandamme, AM; Bertazzoni, U; Salemi, M;
PUBLISHED: 2000, SOURCE: Anton Dohrn Workshop on Neutralism and Selectionism - the End of a Debate in GENE, VOLUME: 261, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
306
TITLE: Compliance is significantly better in HAART responders compared to non-responders
AUTHORS: Vandamme, AM; Van Vaerenbergh, K; Deschamps, A; De Graeve, V; De Saar, V; Maes, B; Ceunen, H; De Smet, K; Peetermans, W; Bobbaers, H; Van Ranst, M; Desmyter, J; De Clercq, E; Van Wijngaerden, E; De Geest, S;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14
INDEXED IN: WOS
307
TITLE: Initiation of HAART in drug naive HIV-1 patients prevents viral breakthrough for up to 43 months in 60% of the patients
AUTHORS: Vandamme, AM; Van Vaerenbergh, K; Schmit, JC; Schmidt, B; Walter, H; Fontaine, E; Schmitt, M; Van Laethem, K; Rascu, A; De Vroey, V; Grunke, M; Low, P; Van Ranst, M; Desmyter, J; De Clercq, E; Harrer, T;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14
INDEXED IN: WOS
308
TITLE: Non-adherence to HAART: clinically relevant patient categorisation based on electronic event monitoring
AUTHORS: Van Wijngaerden, E; De Saar, V; De Graeve, V; Vandamme, AM; Van Vaerenbergh, K; Bobbaers, H; Deschamps, A; Ceunen, H; De Geest, S;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14
INDEXED IN: WOS
309
TITLE: Evaluation of two commercial kits for the detection of genotypic drug-resistance on a panel of HIV-1 subtypes A-J
AUTHORS: Fontaine, E; Riva, C; Peeters, M; Schmit, JC; Delaporte, E; Van Laethem, K; Van Vaerenbergh, K; Van Wijngaerden, E; Van Ranst, M; Vandamme, AM;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14
INDEXED IN: WOS
310
TITLE: Performance of the new ViroSeq (TM) HIV-1 genotyping system (version 2) with group M subtype panel and with subtype B clinical samples at test sites
AUTHORS: Dileanis, J; Marlowe, N; Hoo, B; Brown, RC; Buimer, M; Huang, D; Palumbo, F; Schuurman, R; Van Laethem, K; Vandamme, AM; Elbeik, T;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14
INDEXED IN: WOS
Page 31 of 42. Total results: 418.